Abstract
Genome-wide association studies have greatly increased the number of T2DM associated risk variants but most of them have focused on populations of European origin. There is scarcity of such studies in developing countries including Pakistan. High prevalence of T2DM in Pakistani population prompted us to design this study. We have devised a two stage (the discovery stage and validation stage) case-control study in Pashtun ethnic population in which 500 T2DM cases and controls each have been recruited to investigate T2DM genetic risk variants. In discovery stage Whole Exome Sequencing (WES) was used to identify and suggest T2DM pathogenic SNPs, based on SIFT and Polyphen scores; whereas in validation stage the selected variants were confirmed for T2DM association using MassARRAY genotyping and appropriate statistical tests. Results of the study showed the target positive association of rs1801282/PPARG (OR = 1.24, 95%Cl = 1.20–1.46, P = 0.010), rs745975/HNF4A (OR = 1.30, 95%Cl = 1.06–1.38, P = 0.004), rs806052/GLIS3 (OR = 1.32, 95%Cl = 1.07–1.66, P = 0.016), rs8192552/MTNR1B (OR = 1.53, 95%Cl = 0.56–1.95, P = 0.012) and rs1805097/IRS-2 (OR = 1.27, 95%Cl = 1.36–1.92, P = 0.045), with T2DM; whereas rs6415788/GLIS3, rs61788900/NOTCH2, rs61788901/NOTCH2 and rs11810554/NOTCH2 (P>0.05) showed no significant association. Identification of genetic risk factors/variants can be used in defining high risk subjects assessment, and disease prevention.
Funder
Higher Education Research Department, Government of Khyber Pakhtunkhwa
Publisher
Public Library of Science (PLoS)
Reference61 articles.
1. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021;American Diabetes Association;Diabetes Care,2021
2. Type 2 Diabetes Mellitus: A Pathophysiologic Perspective;EC Westman;Frontiers in nutrition,2021
3. Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls;JC Henquin;Scientific reports,2017
4. Defining the underlying defect in insulin action in type 2 diabetes;TM Batista;Diabetologia,2021
5. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients;P Marchetti;Diabetologia,2007